Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear

Hearing Research

Volumn 212, Issue 1-2, 2006, Pages 22-32

  Trune, Dennis R ^a   Kempton, J Beth ^a   Gross, Neil D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aldosterone; Autoimmune hearing loss; Mineralocorticoid; MRL MpJ Faslpr autoimmune mice; Prednisolone; Spironolactone

Indexed keywords

ALCOHOL; ALDOSTERONE; GLUCOCORTICOID; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; PREDNISOLONE; SPIRONOLACTONE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; COCHLEA; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG MIXTURE; DRUG TOLERANCE; ENDOLYMPH; HEARING LOSS; HEMATOCRIT; HOMEOSTASIS; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC DISEASE;

ALDOSTERONE; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; AUDITORY THRESHOLD; AUTOIMMUNE DISEASES; BODY WEIGHT; COCHLEA; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GLUCOCORTICOIDS; HEARING LOSS, SENSORINEURAL; HEMATOCRIT; MICE; PREDNISOLONE; RANDOM ALLOCATION; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE;

EID: 32844454421     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2005.10.006     Document Type: Article

References (59)

1. --cotransporter abundance: role of aldosterone J. Am. Soc. Nephrol. 12 2001 1335 1341
2. C. Alexiou, W. Arnold, C. Fauser, B. Schratzenstaller, B. Gloddek, S. Fuhrmann, and K. Lamm Sudden sensorineural hearing loss: does application of glucocorticoids make sense? Arch. Otolaryngol. Head Neck Surg. 127 2001 253 258
3. E.S. Alnemri, A.B. Maksymowych, N.M. Robertson, and G. Litwack Overexpression and characterization of the human mineralocorticoid receptor J. Biol. Chem. 266 1991 18072 18081
4. J.L. Arriza, C. Weinberger, G. Cerelli, T.M. Glaser, B.L. Handelin, D.E. Housman, and R.M. Evans Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor Science 237 1987 268 275
5. P.J. Barnes, and I. Adcock Anti-inflammatory actions of steroids: molecular mechanisms Trends Pharm. Sci. 14 1993 436 441
6. + channels J. Membrane Biol. 143 1995 1 18
7. T.J. Campen, and D.D. Fanestil Spironolactone: a glucocorticoid agonist or antagonist? Clin. Exper. Hyperten. Theory Pract. A4 1982 1627 1636
8. M. Claire, H. Faraj, G. Grassy, A. Aumelas, A. Rondot, and G. Auzou Synthesis of new 11β-substituted spironolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptors J. Med. Chem. 36 1993 2404 2407
9. J.N. Clore, H. Estep, H. Ross-Clunis, and C.O. Watlington Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486 J. Clin. Endocrinol. Metab. 67 1988 824 831
10. B. Couette, V. Marsaud, E.-E. Baulieu, H. Richard-Foy, and M.-E. Rafestin-Oblin Spironolactone, an aldosterone antagonist, acts as an antiglucorticoid on the mouse mammary tumor virus promoter Endocrinology 130 1992 430 436
11. E. Falkenstein, M. Christ, M. Feuring, and M. Wehling Specific nongenomic actions of aldosterone Kid. Int. 57 2000 1390 1394
12. J.W. Funder Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance Ann. Rev. Med. 48 1997 231 240
13. H. Furuta, N. Mori, C. Sato, H. Hoshikawa, S. Sakai, S. Iwakura, and K. Doi Mineralocorticoid type I receptor in the rat cochlea: mRNA identification by polymerase chain reaction (PCR) and in situ hybridization Hear. Res. 78 1994 175 180
14. H. Garty, and L.G. Palmer Epithelial sodium channels: function, structure, and regulation Physiol. Rev. 77 1997 359 396
15. J.R. Grandis, B.E. Hirsch, and M.M. Wagener Treatment of idiopathic sudden sensorineural hearing loss Am. J. Otol. 14 1993 183 185
16. N.D. Gross, J.B. Kempton, and D.R. Trune Spironolactone blocks glucocorticoid mediated hearing preservation in autoimmune mice Laryngoscope 112 2002 298 303
17. A. Hausler, C. Persoz, R. Buser, C. Mondadori, and A. Bhatnagar Adrenalectomy, corticosteroid replacement and their importance for drug-induced memory-enhancement in mice J. Steroid Biochem. Mol. Biol. 41 1992 785 789
18. J.D. Horisberger, and B.C. Rossier Aldosterone regulation of gene transcription leading to control of ion transport Hypertension 19 1992 221 227
19. I.M. Hunneyball, M.J. Crossley, and M. Spowage Pharmacological studies of antigen-induced arthritis in BALB/c mice. I. Characterization of the arthritis and the effect of steroidal and non-steroidal anti-inflammatory agents Agents Actions 18 1986 384 393
20. lpr autoimmune mice. Presented at the Assoc Res Otolaryngol Midwinter Mtg, St. Petersburg Beach, Jan.
21. + channels in the amphibian cell line A6 is not altered by mineralocorticoids. Analysis using a new photoactive amiloride analog in combination with anti-amiloride antibodies J. Biol. Chem. 264 1989 11995 12000
22. O. Lesouhaitier, A. Chiappe, and M.F. Rossier Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing gene expression Endocrinology 142 2001 4320 4330
23. D.W. Lin, and D.R. Trune Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice Otolaryngol. Head Neck Surg. 117 1997 530 534
24. F. Luzzani, and A. Glasser Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates Biochem. Pharm. 33 1984 2277 2281
25. G.T. McInnes, J.R. Shelton, L.E. Ramsay, I.R. Harrison, M.J. Asbury, J.M. Clarke, R.M. Perkins, and G.R. Venning Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience Brit. J. Clin. Pharm. 13 1982 331 339
26. C.R. Mitchell, J.B. Kempton, T.A. Creedon, and D.R. Trune The use of a 56-stimulus train for the rapid acquisition of auditory brainstem responses with multiple frequency and intensity tone-bursts Audiol. Neurootol. 4 1999 80 87
27. D. Moskowitz, K.J. Lee, and H.W. Smith Steroid use in idiopathic sudden sensorineural hearing loss Laryngoscope 94 1984 664 666
28. S.K. Mujais, M.A. Chekal, W.J. Jones, J.P. Hayslett, and A.I. Katz Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules J. Clin. Invest. 76 1985 170 176
29. A. Munck, D.B. Mendel, L.I. Smith, and E. Orti Glucocorticoid receptors and actions Am. Rev. Respir. Dis. 141 1990 S2 S10
30. D.D. Murphy Lymphoproliferation (lpr) and other single-locus models for murine lupus M.E. Gershwin B. Merchant Immunologic Defects in Laboratory Animals. vol. 2 1981 Plenum Press New York 143 173
31. D.M. Nadel The use of systemic steroids in otolaryngology ENT-Ear Nose Throat J. 75 1996 502 516
32. +-ATPase sites in the mammalian inner ear Brain Res. 601 1993 273 278
33. D.Z. Pitovski, M.J. Drescher, and D.G. Drescher High affinity aldosterone binding sites (Type I receptors) in the mammalian inner ear Hear. Res. 69 1993 10 14
34. K.E. Rarey, P.J.F.M. Lohuis, and W.-J.F. ten Cate Response of the stria vascularis to corticosteroids Laryngoscope 101 1991 1081 1084
35. M.J. Ruckenstein, R.J. Mount, and R.V. Harrison The MRL-lpr/lpr mouse: a potential model of autoimmune inner ear disease Acta Otolaryngol. 113 1993 160 165
36. lpr autoimmune mouse Otolaryngol. Head Neck Surg. 121 1999 452 456
37. R. Rupprecht, J.M.H.M. Reul, B. van Steensel, D. Spengler, M. Soder, B. Berning, F. Holsboer, and K. Damm Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands Eur. J. Pharm. Mol. Pharm. 247 1993 145 154
38. C.L. Sage, and D.C. Marcus Immunolocalization of ClC-K chloride channel in strial marginal cells and vestibular dark cells Hear. Res. 160 2001 1 9
39. B.P. Schimmer, and K.L. Parker Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Ruddon Goodman and Gilman's The Pharmacological Basis of Therapeutics ninth ed. 1996 McGraw-Hill Companies New York 1459 1485
40. P.J. Smith, D.J. Cousins, Y.-K. Jee, D.Z. Staynov, T.H. Lee, and P. Lavender Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elements J. Immunol. 167 2001 2502 2510
41. S. Takeuchi, M. Ando, T. Sata, and A. Kakigi Three-dimensional and ultrastructural relationships between intermediate cells and capillaries in the gerbil stria vascularis Hear. Res. 155 2001 103 112
42. W.J.F. ten Cate, L.M. Curtis, G.M. Small, and K.E. Rarey Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea Laryngoscope 103 1993 865 871
43. W.J.F. ten Cate, C. Monder, A. Marandici, and K.E. Rarey 11β-hydroxysteroid dehydrogenase in the rat inner ear Am. J. Physiol. 266 1994 E269 E273
44. D.R. Trune Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss Otolaryngol. Head Neck Surg. 117 1997 504 508
45. D.R. Trune Mouse models for immunologic diseases of the auditory system J.F. Willott Handbook of Mouse Auditory Research: From Behavior to Molecular Biology 2001 CRC Press Boca Raton 505 531
46. lpr autoimmune mice Hear. Res. 155 2001 9 20
47. D.R. Trune, J.P. Craven, J.I. Morton, and C. Mitchell Autoimmune disease and cochlear pathology in C3H/lpr strain mouse Hear. Res. 38 1989 57 66
48. D.R. Trune, J.B. Kempton, S.H. Hefeneider, and R.M. Bennett Inner ear DNA receptors in MRL/lpr autoimmune mice: potential 30 and 70 kilodalton link between autoimmune disease and hearing loss Hear. Res. 105 1997 57 64
49. lpr autoimmune mouse Hear. Res. 137 1999 160 166
50. lpr autoimmune mice prevents cochlear dysfunction Hear. Res. 137 1999 167 173
51. P.M. Van der Kraan, E.L. Vitters, N.S. Postma, J. Verbunt, and W.B. van den Berg Maintenance of the synthesis of large proteoglycans in anatomically intact murine articular cartilage by steroids and insulin-like growth factor I Ann. Rheum. Dis. 52 1993 734 741
52. G. Wambach, and J. Casals-Stenzel Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo Biochem. Pharm. 32 1983 1479 1485
53. + cycling and the endocochlear potential Hear. Res. 165 2002 1 9
54. R. Watanabe-Fukunaga, C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 356 1992 314 317
55. P.C. Weber, C.D. Cunningham III, and B.A. Schulte Potassium recycling pathways in the human cochlea Laryngoscope 111 2001 1156 1165
56. W.R. Wilson, F.M. Byl, and N. Laird The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study Arch. Otolaryngol. 106 1980 772 776
57. X. Yao, and K.E. Rarey Localization of the mineralocorticoid receptor in rat cochlear tissue Acta Otolaryngol. 116 1996 493 496
58. Z.-H. Zhou, and J.K. Bubien Nongenomic regulation of ENaC by aldosterone Am. J. Physiol. Cell Physiol. 281 2001 C1118 C1130
59. N.N. Zhou, S. Nikai, T. Kawakita, M. Oka, H. Nagasawa, K. Himeo, and K. Nomoto Combined treatment of autoimmune MRL/MP-lpr/lpr mice with a herbal medicine, Ren-shen-yang-rong-tang (Japanese name: Ninin-Youyi-to) plus suboptimal dosage of prednisolone Int. J. Immunopharm. 16 1994 845 854